PharmaShots | Incisive News in 3 Shots

Subscribe Now

NextCure

NextCure Entered into a Collaboration and Co-Development Agreement with LegoChem Biosciences to Develop Antibody Drug Conjugates for Cancer

NextCure Entered into a Collaboration and Co-Development Agreement with LegoChem Biosciences to Develop Antibody Drug Conjugates f...

November 16, 2022

$NextCure Reports Initiation of NC410 + Keytruda in P-Ib/II Clinical Trial for Immune Checkpoint Refractory or Naïve Solid Tumors$

NextCure Reports Initiation of NC410 + Keytruda in P-Ib/II Clinical Trial for Immune Checkpoint Refractory or Naïve Solid Tumors

October 5, 2022

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

February 11, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us